GlobeStar Therapeutics Corp Annual Interest Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
GlobeStar Therapeutics Corp quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
  • GlobeStar Therapeutics Corp Interest Expense for the quarter ending June 30, 2024 was $4.3K, a 56.8% decline year-over-year.
  • GlobeStar Therapeutics Corp Interest Expense for the twelve months ending June 30, 2024 was $82.4K, a 95.3% increase year-over-year.
  • GlobeStar Therapeutics Corp annual Interest Expense for 2023 was $91.6K, a 30.2% increase from 2022.
  • GlobeStar Therapeutics Corp annual Interest Expense for 2022 was $70.3K, a 75.5% decline from 2021.
  • GlobeStar Therapeutics Corp annual Interest Expense for 2021 was $287K, a 20.8% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $91.6K +$21.3K +30.2% Oct 1, 2022 Sep 30, 2023 10-K 2024-01-19
2022 $70.3K -$217K -75.5% Oct 1, 2021 Sep 30, 2022 10-K 2024-01-19
2021 $287K +$49.4K +20.8% Oct 1, 2020 Sep 30, 2021 10-K 2023-01-09
2020 $238K -$122K -33.9% Oct 1, 2019 Sep 30, 2020 10-K 2022-01-05
2019 $360K +$257K +248% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-03
2018 $103K -$532K -83.7% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-31
2017 $636K Oct 1, 2016 Sep 30, 2017 10-K 2019-01-03
2015 $388K -$400K -50.7% Oct 1, 2014 Sep 30, 2015 10-K/A 2016-01-22
2014 $788K +$487K +162% Oct 1, 2013 Sep 30, 2014 10-K/A 2016-01-22
2013 $301K +$137K +83.1% Oct 1, 2012 Sep 30, 2013 10-K/A 2015-01-27
2012 $164K Oct 1, 2011 Sep 30, 2012 10-K/A 2014-01-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.